sample collection
sample collection is an intervention with 67 clinical trials. Currently 23 active trials ongoing. Historical success rate of 89.7%.
Success Metrics
Based on 26 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.7%
26 of 30 finished
13.3%
4 ended early
23
trials recruiting
67
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Speckle Tracking Echocardiography as a Tool for Early Diagnosis of Impaired Fetal Growth Twin Pregnancies
Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic Cancers
Study Evaluating the Effect of UCB8600 on Mast Cell Activation in the Human Gut
Exosome Cargo From Preeclampsia Patients
Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor
Clinical Trials (67)
Speckle Tracking Echocardiography as a Tool for Early Diagnosis of Impaired Fetal Growth Twin Pregnancies
Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic Cancers
Study Evaluating the Effect of UCB8600 on Mast Cell Activation in the Human Gut
Exosome Cargo From Preeclampsia Patients
Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor
Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test
Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone
CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2
Johns Hopkins Breast Cancer Program Longitudinal Repository
Longitudinal Oral Microbiome Sampling for BE
Oral Microbiome in Carotid Atherosclerosis
iSITE: Investigation of Somatic Alterations in Tumours of the Eye
Diabetes Reversal and the Subgingival Microbiota
Observational Study of Exposure to Environmental Toxicants Among Firefighters
Omics of Rituximab-resistance
A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients
Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario
Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19
Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancreatic Cancer
Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 67